Leukovorin (Folinic Acid) Dosage and Administration in Chemotherapy Regimens
Leukovorin dosage in chemotherapy regimens varies by protocol, with standard doses ranging from 200-500 mg/m² IV depending on the specific regimen, with administration timing carefully coordinated with 5-FU or methotrexate administration to maximize efficacy and minimize toxicity. 1
Standard Dosing in Common Colorectal Cancer Regimens
FOLFOX Regimens
FOLFOX 4:
- Leucovorin 200 mg/m² IV over 2 hours, days 1 and 2
- Followed by 5-FU 400 mg/m² IV bolus, then 600 mg/m² IV over 22 hours continuous infusion, days 1 and 2
- Repeat every 2 weeks 1
mFOLFOX 6:
- Leucovorin 400 mg/m² IV over 2 hours, day 1
- Followed by 5-FU 400 mg/m² IV bolus on day 1, then 1200 mg/m²/day × 2 days continuous infusion
- Repeat every 2 weeks 1
FOLFIRI Regimen
- Leucovorin 400 mg/m² IV infusion to match duration of irinotecan infusion, day 1
- Followed by 5-FU 400 mg/m² IV bolus day 1, then 1200 mg/m²/day × 2 days continuous infusion
- Repeat every 2 weeks 1
FOLFOXIRI Regimen
- Leucovorin 400 mg/m² day 1
- With irinotecan 165 mg/m² IV day 1, oxaliplatin 85 mg/m² day 1
- Followed by fluorouracil 3200 mg/m² over 48-hour continuous infusion starting on day 1
- Repeat every 3 weeks 1
Bolus or Infusional 5-FU/Leucovorin Regimens
Roswell-Park regimen:
- Leucovorin 500 mg/m² IV over 2 hours, days 1,8,15,22,29, and 36
- 5-FU 500 mg/m² IV bolus 1 hour after start of leucovorin
- Repeat every 8 weeks 1
Biweekly regimen:
- Leucovorin 200 mg/m² IV over 2 hours, days 1 and 2
- 5-FU 400 mg/m² IV bolus, then 600 mg/m² IV over 22 hours continuous infusion, days 1 and 2
- Repeat every 2 weeks 1
Simplified biweekly (sLV5FU2):
- Leucovorin 400 mg/m² IV over 2 hours on day 1
- Followed by 5-FU bolus 400 mg/m² and then 1200 mg/m²/day × 2 days continuous infusion
- Repeat every 2 weeks 1
Weekly regimen:
- Leucovorin 20 mg/m² as a 2-hour infusion
- 5-FU 500 mg/m² bolus administered 1 hour after LV infusion
- Repeat weekly 1
Important Dosing Considerations
Levoleucovorin Equivalence
- Levoleucovorin dose is 200 mg/m², which is equivalent to leucovorin 400 mg/m² 1
- This equivalence must be considered when substituting between the two forms
Rectal Cancer-Specific Regimens
For concurrent chemotherapy/RT in rectal cancer:
- XRT + 5-FU/leucovorin:
- 5-FU 400 mg/m² IV bolus + leucovorin 20 mg/m² IV bolus for 4 days during weeks 1 and 5 of XRT 1
Methotrexate Rescue
For high-dose methotrexate toxicity or delayed elimination:
- Start leucovorin rescue within 24 hours of methotrexate administration
- Initial dose: 15 mg (10 mg/m²) IM, IV, or PO every 6 hours until serum methotrexate level is less than 10⁻⁸ M
- If 24-hour serum creatinine increases 50% over baseline or if 24-hour methotrexate level is greater than 5 × 10⁻⁶ M (or 48-hour level is greater than 9 × 10⁻⁷ M), increase leucovorin to 150 mg (100 mg/m²) IV every 3 hours until methotrexate level is less than 10⁻⁸ M 2
- Doses greater than 25 mg should be given parenterally due to saturable oral absorption 2
Administration Pearls and Pitfalls
Key Administration Points
- Leucovorin should be administered before 5-FU in most regimens to optimize biochemical modulation
- For FOLFIRI, leucovorin infusion should match the duration of irinotecan infusion 1
- For methotrexate rescue, parenteral administration is preferred when GI toxicity, nausea, or vomiting is present 2
Potential Pitfalls to Avoid
- Oral absorption limitation: Oral administration of doses greater than 25 mg is not recommended due to saturable absorption 2
- Timing errors: Incorrect timing of leucovorin relative to 5-FU can reduce efficacy
- Dosing errors: NCCN recommends limiting chemotherapy orders to 24-hour units (i.e., 1200 mg/m²/day NOT 2400 mg/m²/day over 46-48 hours) to minimize medication errors 1
- Inadequate rescue: Insufficient leucovorin dosing in methotrexate toxicity can lead to severe complications
- Delayed rescue: Leucovorin rescue for methotrexate toxicity should begin as soon as possible and within 24 hours of methotrexate administration 2
Special Considerations
- Hydration (3 L/day) and urinary alkalinization with sodium bicarbonate should be employed concomitantly with leucovorin rescue for methotrexate toxicity 2
- Patients with delayed methotrexate elimination require continuing hydration, urinary alkalinization, and close monitoring of fluid and electrolyte status until serum methotrexate level falls below 0.05 micromolar 2
- Consider potential drug interactions that may interfere with methotrexate elimination or binding to serum albumin when laboratory abnormalities or clinical toxicities are observed 2